Position in CGC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,848,977
-$20,207 QoQ
Shares Held
1,946,294
-1.2% QoQ
Ownership
0.460%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 212 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,440,445 across 76 Drug Manufacturers - Specialty & Generic names. CGC ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in CGC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,848,977 | 1,946,294 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,869,184 | 1,969,640 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,353,929 | 2,064,852 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,447,328 | 1,676,253 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,474,578 | 1,208,673 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,103,785 | 1,212,954 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,609,563 | 952,396 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,356,454 | 903,829 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $3,371,200 | 522,667 | Shares | Defined | 2024-10-17 | |
| 2024-03-31 | $5,032,505 | 583,141 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,061,780 | 207,785 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,514,785 | 1,934,593 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,244,061 | 3,206,348 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,567,757 | 1,467,291 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,970,002 | 2,151,517 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,354,939 | 3,793,019 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,093,936 | 2,839,979 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $14,554,415 | 1,920,108 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $14,023,745 | 1,606,386 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,991,254 | 2,813,222 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $50,559,046 | 2,090,945 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $64,109,965 | 2,001,560 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $39,365,552 | 1,597,628 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $21,842,123 | 1,525,288 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,283,928 | 1,378,956 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,459,297 | 794,681 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||